Analyst Ranking
Top 21%
#1032 out of 4995 analysts
Average Return
+10.14%
Win Rate
50%23 out of 46
Risk vs Reward
Poor
Good

Cory Kasimov's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Bluebird Bio IncBLUE
+369.12%$733.20$3,439.60
2014-06-18 -
2015-06-18
Strong Buy
Gilead Sciences IncGILD
+90.55%$32.90$62.69
2012-09-17 -
2013-09-17
Strong Buy
Bridgebio Pharma IncBBIO
+87.33%$23.92$44.81
2024-08-07 -
2025-08-06
Buy
Karuna Therapeutics IncKRTX
+83.52%$122.33$224.50
2021-09-30 -
2022-09-29
Strong Buy
Bridgebio Pharma IncBBIO
+76.74%$27.77$49.08
2024-12-23 -
2025-08-22
Buy

Cory Kasimov Analyst Color

Get additional color on Cory Kasimov's coverage of popular stocks

Cory Kasimov's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Immunome IncIMNM
1Buy$18.00+74.76%Initiates Coverage On
3 days ago
Summit Therapeutics IncSMMT
2Buy$34.00+29.77%Maintains
13 days ago
Xenon Pharmaceuticals IncXENE
1Buy$55.00+41.61%Initiates Coverage On
3 months ago
Moderna IncMRNA
5Hold$32.00+17.99%Maintains
4 months ago
Neurocrine Biosciences IncNBIX
2Buy$185.00+36.60%Maintains
4 months ago
Springworks Therapeutics IncSWTX
2Buy$65.00+38.33%Maintains
6 months ago
Bridgebio Pharma IncBBIO
3Buy$50.00+1.87%Maintains
8 months ago
Edgewise Therapeutics IncEWTX
2Buy$50.00+236.70%Maintains
8 months ago
Biontech SeBNTX
3Buy$125.00+12.73%Upgrades
9 months ago
Biomarin Pharmaceutical IncBMRN
4Buy$105.00+79.24%Maintains
10 months ago
Regeneron Pharmaceuticals IncREGN
4Buy$1,175.00+99.33%Maintains
10 months ago
Arcellx IncACLX
1Buy$85.00N/AInitiates Coverage On
a year ago
Ultragenyx Pharmaceutical IncRARE
3Strong Buy$88.00N/AMaintains
a year ago
Karuna Therapeutics IncKRTX
2Strong Buy$250.00N/AMaintains
2 years ago
Cerevel Therapeutics Holdings IncCERE
1Strong Buy$50.00N/AInitiates Coverage On
4 years ago
Biogen IncBIIB
2Hold$276.00N/AMaintains
4 years ago
Sana Biotechnology IncSANA
1Hold$35.00N/AInitiates Coverage On
4 years ago
Bluebird Bio IncBLUE
5Hold$780.00N/ADowngrades
5 years ago
Incyte CorpINCY
2HoldN/AN/ADowngrades
5 years ago
Alexion Pharmaceuticals IncALXN
1Strong Buy$163.00N/AMaintains
5 years ago
Alkermes PLCALKS
2Hold$21.00N/ADowngrades
6 years ago
Jounce Therapeutics IncJNCE
4Strong SellN/AN/ADowngrades
7 years ago
Puma Biotechnology IncPBYI
4Strong Sell$23.00N/AMaintains
7 years ago
Clovis Oncology IncCLVSQ
5Hold$16.00N/ADowngrades
7 years ago
Amgen IncAMGN
2Hold$192.00N/AMaintains
7 years ago
Spark Therapeutics IncONCE
3Hold$63.00N/AMaintains
7 years ago
Celgene CorpCELG
1Strong Buy$110.00N/AReinstates
7 years ago
Lexicon Pharmaceuticals IncLXRX
1Strong Sell$10.00N/AMaintains
8 years ago
Dynavax Technologies CorpDVAX
1Hold$250.00N/AMaintains
8 years ago
Atyr Pharma IncATYR
2Strong Buy$140.00N/AMaintains
9 years ago
Gilead Sciences IncGILD
1Strong Buy$37.50N/AMaintains
13 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.